Covid-19 Spotlight Series

LABEST Presents COVID19 Spotlight Series - Clinical Research

Manish J. Butte, MD, PhD, Chief of the Division of Allergy, Immunology and Rheumatology – He leads the hyperimmune antibody clinical studies for COVID-19

Judith S. Currier, MD, Division Chief, Infectious Diseases - Her areas of research focus include understanding the pathogenesis and management of long term complications of HIV disease. Her focus will be on UCLA and Los Angeles clinical infrastructure coordination during the COVID-19 pandemic.

Arash Naeim, MD, PhD, Chief Medical Officer for Clinical Research - His research interests include outcomes research, cost-effectiveness analysis, modeling of health and frailty, and clinical trial design. His focus is on the COVID-19 data and specimen registry and clinical research innovations.

Alyssa Ziman MD, Director of Transfusion Medicine - She is leading the Convalescent Plasma Study to help fight COVID-19

LABEST presents COVID-19 SPOTLIGHT SERIES Therapeutics and Vaccines

Dr. Vaithilingaraja Arumugaswami, Virologist and Associate Professor, Department of Molecular and Medical Pharmacology develops vaccines against a broad range of viruses and is currently investigating the pathogenesis of the novel coronavirus to design an effective vaccine

Dr. Brigitte Gomperts, Professor of Pediatrics and Pulmonary Medicine investigates lung repair and regeneration and is exploring therapies against COVID-19

Dr. Robert Damoiseaux, a High Throughput Screening (HTS) expert and Professor, Department of Molecular and Medical Pharmacology. His research interests focus on the development of novel HTS technologies.

Dr. Otto Yang, Professor of Medicine, has developed immunotherapies and nanoparticle vaccines against HIV and other viruses and is currently investigating their application to COVID-19.

LABEST presents COVID-19 SPOTLIGHT SERIES A Multi-Faceted Approach

Ren Sun, a professor of molecular and medical pharmacology who is developing saliva test strips to diagnose SARS-Cov-2, the virus that causes COVID-19.

Daniel Kamei, a professor of bioengineering who develops point-of-care diagnostic technology that could be applied to detecting COVID-19 detection.

Eran Halperin, a professor of computational medicine who is a co-lead on UCLA’s Stop Covid-19 Together initiative, which is crowdsourcing data from participants to help researchers understand how the coronavirus pandemic is affecting different communities.